| Tyler Harano, | |
|
201 W North River Dr Ste 301, Spokane, WA 99201-2262 | |
| (509) 903-0103 | |
| Not Available |
| Full Name | Tyler Harano |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 201 W North River Dr Ste 301, Spokane, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043072945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 204962 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tyler Harano, 4490 Eldorado Pkwy Apt 528, Mckinney, TX 75070-3880 Ph: (805) 416-6760 | Tyler Harano, 201 W North River Dr Ste 301, Spokane, WA 99201-2262 Ph: (509) 903-0103 |
News Archive
For the first time, researchers have demonstrated that the administration of minute amounts of inhaled or intravenous hydrogen sulfide, or H2S - the molecule that gives rotten eggs their sulfurous stench - significantly improves survival from extreme blood loss in rats.
Parents and caregivers are hearing and following the feeding guidance for infants, yet continued work needs to be done to help them also build good eating habits for their growing children, suggests data from the Nestle Feeding Infants and Toddlers Study (FITS) released today at a symposium at the American Dietetic Association's Food & Nutrition Conference & Expo.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Researchers have designed a safer, faster and cheaper cell-based regenerative therapy approach for the treatment of one of the most common human dental diseases, namely periodontitis.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that data for the company's novel visual cycle modulator, ACU-4429, a potential oral treatment for dry age-related macular degeneration (dry AMD), will be featured at the 8th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) being held in Rome, Italy from December 3 to 6, 2009.
› Verified 4 days ago
John Stifter, LMHC, LMFTA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1404 E 11th Ave, Spokane, WA 99202 Phone: 509-744-1117 | |
Taylor Svetlichny, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3708 W Wellesley Ave, Spokane, WA 99205 Phone: 808-722-1205 | |
Aislinn Noone, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 222 W Mission Ave Ste 122, Spokane, WA 99201 Phone: 509-842-0067 | |
Chelsea Hansen, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 200 N Bernard St, Spokane, WA 99201 Phone: 509-354-7946 | |
Ms. Jeana N Paul, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 107 S Division St, Spokane, WA 99202 Phone: 509-838-4651 Fax: 509-363-2762 | |
Mrs. Ana Elisa Pereira Caminada-hopkins, LMFTA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 101 W Cascade Way Ste 103, Spokane, WA 99208 Phone: 509-413-2242 | |
Katherine Campbell, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 200 N Bernard St, Spokane, WA 99201 Phone: 509-354-7946 |